EGFR and neoplasm: Collectively our results suggested that EGFR, MAP2K1, mTOR, TEAD1, and YAP1 could mediate invasive tumor phenotypes and produce worse prognoses via mechanisms involving both the T-cell exclusion and dysfunctional phenotypes.